ReviewExperimental hematology & oncology2017

Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.

Shengnan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.